The latest news from oncology events around the world
Patients receiving the anti-CD38 monoclonal antibody isatuximab in addition to the standard three- component induction…
An interim analysis of the TRANSFORM trial comparing CAR T-cell therapy lisocabtagene maraleucel (liso-cel) to…
The Phase II ZUMA-12 trial expands on the ZUMA-1 findings by evaluating the use of axicabtagene ciloleucel…
Follow-up data from the Phase II ZUMA-5 trial showed a long-term survival benefit with axicabtagene ciloleucel (axi-cel)…
A phase I/II trial for the experimental drug mosunetuzumab met its primary endpoint, leading to…
A combination of five existing drugs keeps cancer at bay for longer in patients with…
The first results from the largest screening study yet conducted in the United States of…
A subgroup analysis of a phase III study led by researchers at the UCLA Jonsson…
Black women experienced higher rates of breast cancer-related lymphedema than white women, and Black race…
A widely used and inexpensive Type 2 diabetes drug, once hoped to hold enormous promise…